Evidence map›Paper›PMID 36230639›Full record

ReviewCancers2022

Mutation Patterns in Portuguese Families with Hereditary Breast and Ovarian Cancer Syndrome.

Rodrigo Vicente, Diogo Alpuim Costa, Marina Vitorino, Ana Duarte Mendes, Catarina Santos, Mário Fontes-Sousa

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. DNA damage targeted therapy for advanced breast cancer.Exploration of targeted anti-tumor therapy · 2024
    Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Rodrigo VicenteMedical Oncology Department, Hospital Professor Doutor Fernando Fonseca, IC19 276, 2720-276 Amadora, Portugal.ORCID 0000-0001-6780-4271
Diogo Alpuim CostaBreast Cancer Unit, CUF Oncologia, 1998-018 Lisbon, Portugal.ORCID 0000-0002-1377-3032
Marina VitorinoMedical Oncology Department, Hospital Professor Doutor Fernando Fonseca, IC19 276, 2720-276 Amadora, Portugal.
Ana Duarte MendesMedical Oncology Department, Hospital Professor Doutor Fernando Fonseca, IC19 276, 2720-276 Amadora, Portugal.
Catarina SantosMedical Oncology Department, Hospital Professor Doutor Fernando Fonseca, IC19 276, 2720-276 Amadora, Portugal.
Mário Fontes-SousaBreast Cancer Unit, CUF Oncologia, 1998-018 Lisbon, Portugal.
Hospital Prof. Dr. Fernando Fonseca · PTCUF Porto Hospital · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Germline pathogenic variants in the Breast Cancer Genes 1 (

Indexed as

breast cancerfounder mutationsgenetic testinghereditary breast and ovarian cancer syndromeovarian cancerPortuguese families

Identifiers

PMID36230639
PMCPMC9564125
OpenAlexW4297464288

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.